DON'T BUY

Likes this. Core business is selling broadcast equipment to cable and telcos. Have done a great job of creating shareholder value by selling off non-core assets such as wireless spectrum and real estate in Saskatchewan. Thinks they are kind of getting to the end of the line and he has sold his position.

biotechnology / pharmaceutical

Unlock the latest expert's opinion. Its free

Create a FREE account to see the latest opinions & get alerts about when to buy, sell or hold stocks

Unlock the latest opinion & get signals
DON'T BUY
Recently entered into a financing agreement. Cash strapped. Existing shareholders tend to get totally diluted of their positions.
biotechnology / pharmaceutical
SELL
Ranks near the bottom. Earnings have been shaved by 23%. Recent financing was very dilutive.
biotechnology / pharmaceutical
DON'T BUY
Ranks in the bottom 1% of his database. Earnings estimates have been revised downwards 12% in the last 90 days.
biotechnology / pharmaceutical
DON'T BUY
It is interesting technology. The company is suffering. Give it a pass. He has owned in the past.
biotechnology / pharmaceutical
DON'T BUY
Has very good technology, but unfortunately it is still in the early stages of being rolled out to the medical community. In the bottom 15% of his database. Earnings estimates have been shaved by about 5% in the last 90 days and 20% in the last 60 days. Most recent quarter had a negative earnings surprise. Expected to lose $0.23 in ’06 and $0.15 in ’07.
biotechnology / pharmaceutical
PAST TOP PICK
(A Top Pick Nov 19/03. Down 83%.) Stock did very well for a whle, but the company was not able to make a viable business. Sold off a long time ago.
biotechnology / pharmaceutical
DON'T BUY
A tough one because the company is struggling with a management team that is being paid too much. Not doing well from a sales point of view and one of their competitors is starting to give away products as a bundling package.
biotechnology / pharmaceutical
TRADE
The bane of his existence. Comes back to haunt him. Has not got this one right at all.
biotechnology / pharmaceutical
TRADE
Have had a lot of trouble. Lost their CEO. Have to do more research with management before investing. Have some interesting technology. Starting to look interesting.
biotechnology / pharmaceutical
BUY
Likes the company and their technology. Management team is improving operations, but they get paid way too much money. The question is; are they going to increase their sales base and ultimately sell the company or dwindle as a small cap. Under $1 there's not a whole lot of risk.
biotechnology / pharmaceutical
DON'T BUY
Not expected to earn any money. In the bottom 2% of the database. Year over year sales are down 43% and earnings down 71%.
biotechnology / pharmaceutical
DON'T BUY
CFO is gone and they have laid off the COO. Have sold zero units of their new technology. Running out of cash.
biotechnology / pharmaceutical
BUY on WEAKNESS
Have been looking at it. Been beaten up more than it should be. Entering tax-loss selling season, so it could drop further. Still believes in the technology. New management could make a difference.
biotechnology / pharmaceutical
WAIT
Short term, it won't be good. Expect some tax loss selling in the last quarter. May take 3/4 years to get a big bang. Good product.
biotechnology / pharmaceutical
Showing 1 to 15 of 58 entries

VSM MedTech Ltd.(VSM-T) Rating

Ranking : 1 out of 5

Bullish - Buy Signals / Votes : 0

Neutral - Hold Signals / Votes : 0

Bearish - Sell Signals / Votes : 0

Total Signals / Votes : 0

Stockchase rating for VSM MedTech Ltd. is calculated according to the stock experts' signals. A high score means experts mostly recommend to buy the stock while a low score means experts mostly recommend to sell the stock.

VSM MedTech Ltd.(VSM-T) Frequently Asked Questions

What is VSM MedTech Ltd. stock symbol?

VSM MedTech Ltd. is a OTC stock, trading under the symbol VSM-T on the (). It is usually referred to as or VSM-T

Is VSM MedTech Ltd. a buy or a sell?

In the last year, there was no coverage of VSM MedTech Ltd. published on Stockchase.

Is VSM MedTech Ltd. a good investment or a top pick?

VSM MedTech Ltd. was recommended as a Top Pick by on . Read the latest stock experts ratings for VSM MedTech Ltd..

Why is VSM MedTech Ltd. stock dropping?

Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.

Is VSM MedTech Ltd. worth watching?

In the last year 0 stock analysts on Stockchase covered VSM MedTech Ltd.. The stock is worth watching.

What is VSM MedTech Ltd. stock price?

On , VSM MedTech Ltd. (VSM-T) stock closed at a price of $.